Double, Double, Experts Huddle, Cells And Bioprocess Bubble

Any sufficiently advanced technology is indistinguishable from magic," wrote Arthur C. Clarke. While the biomanufacturing of therapeutic exosomes and extracellular vesicles (EVs) might still feel a bit like alchemy, RoosterBio and Repligen are working to ground it firmly in scientific process.

Facing rising demand for EVs in regenerative medicine and advanced therapeutics, the challenge of scalable, high-quality manufacturing is paramount. This article unpacks key insights from a joint webinar where experts from RoosterBio and Repligen detailed their collaborative approach. By integrating RoosterBio’s innovative upstream production with Repligen’s cutting-edge downstream purification, they're forging a streamlined bioprocess to overcome these hurdles.

Eager to understand how this powerful partnership is refining exosome and EV manufacturing? Uncover the critical insights and future possibilities – read the full article now.